Results 171 to 180 of about 1,763 (188)
Some of the next articles are maybe not open access.

Definitive Radiotherapy for Oligometastatic and Oligoprogressive Thyroid Cancer

International Journal of Radiation Oncology*Biology*Physics, 2023
S.O. Dudzinski   +19 more
openaire   +1 more source

Progression-Directed Therapy for Oligoprogression in Castration-Refractory Prostate Cancer

European Urology Oncology, 2021
Charlien Berghen   +2 more
exaly  

Management of Oligoprogression in Non-Small Cell Lung Cancer Patients

Medical Oncology, 2022
Alfredo Tartarone, Rosa Lerose
exaly  

Management of oligoprogressive and oligopersistent disease in advanced NSCLC.

Clinical advances in hematology & oncology : H&O
The oligometastatic disease state is defined as an intermediate state between localized cancer and widespread systemic metastases. Oligoprogression is defined as a subgroup in which limited metastatic areas are progressing in the background of oligometastatic or polymetastatic disease, whereas oligopersistent disease refers to an induced state in which
Revathi, Ravella   +4 more
openaire   +1 more source

Long-Term Response to Avelumab and Management of Oligoprogression in Merkel Cell Carcinoma: A Case Report

World Journal of Clinical Cases, 2021
Inês Leão, Telma Costa, Joana Marinho
exaly  

Consolidative Use of Radiotherapy to Block (CURB) Oligoprogression - Randomised Study of Stereotactic Body Radiotherapy in Patients with Oligoprogressive Cancers of the Breast and Lung

2023
Chiaojung Jillian Tsai   +27 more
openaire   +1 more source

Phase II Study of Stereotactic Radiosurgery for the Treatment of Patients With Oligoprogression on Erlotinib

Cancer Treatment and Research Communications, 2019
Nathan A Pennell   +2 more
exaly  

Management of Oligoprogression in the Thorax—Are We Making This Too Complicated?

International Journal of Radiation Oncology*Biology*Physics
Pule Wang, Arya Amini
openaire   +2 more sources

Home - About - Disclaimer - Privacy